August 2012 Issue of MMM

August 2012 Issue of MMM

AUGUST 2012 issue

Editor's Desk

There's life beyond the cliff

Obamacare could cost the industry $140 billion—not exactly a windfall


Global Report 2012: The Diabetes Olympics

Merck's Januvia raced to diabetes dominance in many countries. It's a different game for combination products and in emerging markets.

Global Report 2012: Out-of-pocket Pains

Brazilians and Mexicans have enjoyed economic growth and with it, are more prone to chronic disease. But can they afford medications?Why market access factors can ...

The Countdown to the MM&M Awards

The MM&M Awards are just weeks away. Here are the finalists for this year's awards, who were chosen by over 100 top industry leaders and ...

Therapeutic Focus

Therapeutic Focus 2012: Infectious Diseases

Incivek and Victrelis changed the standard of care for treating hepatitis C. But they're not in the lead of a second generation of treatments

Vantage Point

Vantage Point: The Affordable Care Act

Most stakeholders have little or no knowledge of the Act's 1,500 pages of specifics or their implications


The Oraquick home HIV test

Public education remains key to the fight against HIV. The new quick test can be a useful aid in this fight

In Focus

Social solutions top tech in Sanofi contest

The winner of Sanofi's second Data Design Diabetes Innovation Challenge was a community-focused proposition that focuses on face-to-face interactions

Professional Marketing

Massachusetts overturns co-pay ban

After three years of wrangling, drug companies can again offer co-pay coupons in Massachusetts.

GSK to pay $3 billion in fraudulent promotion settlement

GlaxoSmithKline will pay $3 billion to settle charges that it promoted antidepressants Paxil and Wellbutrin for unindicated uses and withheld safety data on diabetes drug ...

Professional Marketing briefs: August 2012

News on Lundbeck, Pfizer and Johnson & Johnson

Med Ed Report

CME's role in FDA opioid safety plan

CME providers may see a modest uptick in funding from the FDA's new safety plan for extended-release and long-acting opioids but may be hard-pressed to ...

GSK settlement reveals junkets

The US Justice Department, as part of its record $3-billion settlement with GlaxoSmithKline, said the drugmaker employed ostensibly scientific meetings to expand the market for ...

Results of EHR study are mixed

Researchers found use of electronic health records (EHRs) over three years does not ensure successful use for improving diabetes care.

Professional Media

Writing a road map to accountability

In an effort to shore up their reputations, pharma and professional publishers have crafted an accountability plan.

American Heart Association publications all go mobile

The American Heart Association's publications are now fully mobile.

Professional Media briefs: August 2012

News on Quadrant Health, Springer Science + Business Media, and The American Journal of Preventive Medicine

Partner Forum

What's the right way to go digital?

How can pharma marketers strategically and safely use digital to reach customers?

Digital Media

'Edu-game' gauges diagnostic skills

A new online medical contest is progressing from the diagnosis of minor ailments to cancer screening.

Device maker tries its hand in the Facebook app arena

Diabetes tech firm Med­tronic rolled out a Facebook strategy to help diabetes patients share milestones.

Digital Media briefs: August 2012

News on iHealth, Deloitte, eMarketer and Sharecard

Consumer Marketing

Merck draws fire for Children's Claritin campaign

An advocacy group wants Merck to back away from a recent Children's Claritin promotion

BI wants cancer care to be social

Boehringer Ingelheim and nonprofit group Cancer Care launched a tool designed to make cancer care social.

Marketing Research

WorldOne snaps up social network Sermo

Healthcare data firm WorldOne has acquired Sermo

Paul is new CEO at EvaluatePharma

EvaluatePharma named Debbie Paul to the position of CEO Americas, EvaluatePharma USA

Agency Business

McCann global network rebrands

McCann Healthcare Worldwide has changed its name to McCann Health, and five of its six US agencies rebranded

Havas brings in UK digital health shop Creative Lynx

Havas is adding Creative Lynx to its Havas Worldwide Health network of healthcare agencies.

Agency Business briefs: August 2012

News on Publicis, Omincom and Double Helix

Beltway Insider

As I See It: FDA's commitment to innovation

It was once thought bizarre to foist a commitment to innovation on a regulatory agency. No longer!

House panel blames FDA for drug shortages

A new report from the House Committee on Oversight and Government Reform blames FDA for shortages of generic injectable medications.

FDA moves faster than EMA: study

A Yale assistant professor and a medical student have provided evidence that FDA's review process is faster than those in other countries.


High-deductible plans: the tsumani is on its way

General Electric converted all of its 300,000+ employees and dependents to HDHPs

When orals attack: how to ensure product access

Remaining a step ahead of these shifts may prove the difference between leaders and followers

Private View

Private View: Veterinary Health

Adam Kline, EVP, Group Creative Director at JUICE Pharma Worldwide.

At Work With

At Work With: Augé Reichenberg

Augé Reichenberg, Executive Creative Director for ­Healthcare, Rosetta


Upward Move: Ed Cowen

Ed Cowen, EVP, Managing Director, Medicus International New York

People Moves: August 2012

Industry, agency and media hires and promotions

Name That Brand

Name That Brand: August 2012

Brand X breaks sales boundaries

Back Talk

Pharma must reboot iPads

For pharma to truly unlock the power of the iPad, we need to evolve the way we look at it